Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02188290 · ClinicalTrials.gov registry record

Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation

A clinical trial, sponsored by Kiadis Pharma.

Completed
Registry status
178
Enrollment target

NCT02188290: Completed study, sponsored by Kiadis Pharma.

NCT02188290 is a clinical trial that has completed, run by Kiadis Pharma. The registered enrollment target is 178 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02188290 has completed, sponsored by Kiadis Pharma.

COMPLETED
Registry status
178 participants
Enrollment target

Study Summary

Study CR-AIR-006 is a part of the ATIR clinical development plan and will provide control data for patients treated with ATIR in clinical studies (e.g. study CR-AIR-007).

Trial Details

FieldValue
Enrollment Target 178 participants
Start Date 2014-09
Est. Completion 2015-06
Kiadis Pharma

4 total trials

What the finished NCT02188290 record still lists

NCT02188290 is an observational study that tracks outcomes without assigning an intervention. The registered 178 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT02188290 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02188290 about?

NCT02188290 is a clinical study titled "Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation". Study CR-AIR-006 is a part of the ATIR clinical development plan and will provide control data for patients treated with ATIR in clinical studies (e.g. study CR-AIR-007).

What is the current status of trial NCT02188290?

This trial is currently completed. The enrollment target is 178 participants. The study started on 2014-09. Estimated completion is 2015-06.

Who is sponsoring clinical trial NCT02188290?

This trial is sponsored by Kiadis Pharma, which has 4 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03642002 · 178 participants · NA

    The Effects of Music Therapy on Adult Patients Requiring Mechanical Ventilation in the ICU

  • NCT04227847 · 178 participants · Phase 1

    A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies

  • NCT04855214 · 178 participants

    Evaluating the Experience of Upper Limb Prosthesis Use

  • NCT05391126 · 178 participants · NA

    GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

Similar registry start date

  • NCT02174549 · started 2014-09 · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

  • NCT02253030 · started 2014-09

    OCT Angiography in Wet AMD

  • NCT02253251 · started 2014-09

    Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment

  • NCT02254863 · started 2014-09 · Phase 1

    UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells

Source: ClinicalTrials.gov NCT02188290, the US trial registry maintained by the National Library of Medicine. NCT02188290 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.